Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries

European Heart Journal

Volumn 22, Issue 22, 2001, Pages 2116-2124

  Sitges, M ^a   Heras, Magda ^a,b   Roig, E ^a   Duran M ^a   Masotti, M ^a   Zurbano, M J ^a   Roque M ^a   Sanz, G ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Endothelial function; Hormone replacement therapy; Oestradiol; Syndrome X

Indexed keywords

ESTRADIOL; EVOPAD; MEDROXYPROGESTERONE; PLACEBO;

ADULT; AGED; ANGINA PECTORIS; ARTERY BLOOD FLOW; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; HORMONE SUBSTITUTION; HUMAN; PERIPHERAL CIRCULATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

AGED; ANGINA PECTORIS; BRACHIAL ARTERY; CIRCADIAN RHYTHM; CORONARY ANGIOGRAPHY; CORONARY VESSELS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; VASCULAR PATENCY; WOMEN'S HEALTH;

EID: 0035176864     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2631     Document Type: Article

References (42)

1. Hormone therapy to prevent disease and prolong life in postmenopausal women
2. 17-Beta-estradiol therapy lessens angina in postmenopausal women with Syndrome X
3. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
4. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
5. Estrogen and cardiovascular function after menopause
6. Female sex hormones and cardiovascular disease in women
7. Estradiol therapy with progesterone and endothelium vasodilation in postmenopausal women
8. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women
9. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease
10. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle
11. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in post-menopausal women with angina pectoris and normal results on coronary angiograms
12. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
13. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
14. Quantitative Doppler blood flow measurement method and in vivo calibration
15. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
16. ™ system
17. Noninvasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility
18. Pathophysiological dilemma of syndrome X
19. Angina pectoris caused by coronary microvascular spasm
20. Syndrome X and endothelial dysfunction
21. The pathogenesis of atherosclerosis
22. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
23. Close relation of endothelial function in the human coronary and peripheral circulations
24. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy
25. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women
26. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
27. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
28. 17 Beta-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary artery disease
29. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women
30. Estrogen acutely increases peripheral blood flow in postmenopausal women
31. Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women
32. Vascular effects of estrogen and vitamin E therapies in postmenopausal women
33. Effects of withdrawal of chronic estrogen therapy on brachial artery vasoreactivity in women with coronary artery disease
34. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
35. Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women
36. Comparative effect of continuos combined hormone replacement therapy regimens on brachial artery blood flow
37. Combined hormone replacement does not protect women against the age-related decline in endothelium-dependent vasomotor function
38. The protective effects of estrogen on the cardiovascular system
39. Nitric oxide: Physiology, pathophysiology and pharmacology
40. New developments in topical estrogen therapy
41. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
42. Effects of long-term transdermal administration of estradiol on serum lipids